Involving patients in cardiovascular risk management with nurse-led clinics: A cluster randomized controlled trial

CMAJ. Canadian Medical Association Journal

Volumn 181, Issue 12, 2009, Pages

  Koelewijn van Loon, Marije S ^a   Van Der Weijden, Trudy ^a,c   Van Steenkiste, Ben ^a   Ronda, Gaby ^a   Winkens, Bjorn ^a   Severens, Johan L ^a,b   Wensing, Michel ^c   Elwyn, Glyn ^c,d   Grol, Richard ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FAT INTAKE; FEMALE; FOOD INTAKE; FRUIT; HUMAN; INTERPERSONAL COMMUNICATION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MORTALITY; NURSING CARE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VEGETABLE;

EID: 73249149879     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081591     Document Type: Article

References (44)

1. Jolliffe JA, Rees K, Taylor RS, et al. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001;(1):CD001800.
2. Ades PA, Pashkow FJ, Nestor JR. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehabil 1997;17:222-31.
3. van Berkel TF, Boersma H, Roos Hesselink JW, et al. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J 1999;20:1773-82.
4. Ebrahim S, Beswick A, Burke M, et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2006;(4):CD001561.
5. Hooper L, Summerbell CD, Higgins JP, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2001;(3):CD002137.
6. Nederlands Huisartsen Genootschapp. M84 NHG-standard cardiovasculair risicomanagement (Dutch guideline for cardiovascular risk management). Houten (the Netherlands): Bohn Stafleu van Loghum; 2006.
7. Laurant M, Reeves D, Hermens R, et al. Substitution of doctors by nurses in primary care. Cochrane Database Syst Rev 2005;(2):CD001271.
8. Laurant MG, Hermens RP, Braspenning JC, et al. Impact of nurse practitioners on workload of general practitioners: randomised controlled trial. BMJ 2004;328:927.
9. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993;270:2207-12.
10. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
11. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10.
12. Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19:239-63.
13. Ashenden R, Silagy C, Weller D. A systematic review of the effectiveness of promoting lifestyle change in general practice. Fam Pract 1997;14:160-76.
14. Lutfey KE, Wishner WJ. Beyond "compliance" is "adherence." Improving the prospect of diabetes care. Diabetes Care 1999;22:635-9.
15. Sabate E. Adherence to long-term therapies. Evidence for action. Geneva (Switzerland): World Health Organization; 2003.
16. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-61.
17. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93:979-89.
18. O'Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ 2003;327:736-40.
19. Elwyn G, Edwards A, Britten N. What information do patients need about medicines? "Doing prescribing": how doctors can be more effective. BMJ 2003;327:864-7.
20. Car J, Sheikh A. Telephone consultations. BMJ 2003;326:966-9.
21. Koelewijn-van Loon MS, van Steenkiste B, Ronda G, et al. Improving Patient Adherence to Lifestyle Advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care (protocol). BMC Health Serv Res 2008;8:9.
22. Edwards A, Unigwe S, Elwyn G, et al. Personalised risk communication for informed decision making about entering screening programs. Cochrane Database Syst Rev 2003;(1):CD001865.
23. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-9.
24. Feldman-Stewart D, Kocovski N, McConnell BA, et al. Perception of quantitative information for treatment decisions. Med Decis Making 2000;20:228-38.
25. Lipkus IM, Hollands JG. The visual communication of risk. J Natl Cancer Inst Monogr 1999;25:149-63.
26. Edwards A, Elwyn G, Covey J, et al. Presenting risk information - a review of the effects of "framing" and other manipulations on patient outcomes. J Health Commun 2001;6:61-82.
27. Timmermans D, Molewijk B, Stiggelbout A, et al. Different formats for communicating surgical risks to patients and the effect on choice of treatment. Patient Educ Couns 2004;54:255-63.
28. van Steenkiste B, van der Weijden T, Stoffers HE, et al. Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. Eur J Cardiovasc Prev Rehabil 2007;14:44-50.
29. Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother 1995;23:325-34.
30. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003;71:843-61.
31. Rollnick S, Mason P, Butler C. Health behavior change. A guide for practitioners. 1st ed. London (UK): Churchill Livingstone; 1999.
32. Rubak S, Sandbaek A, Lauritzen T, et al. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005;55:305-12.
33. Mudde AN, Willemsen MC, Kremers S, et al. Meetinstrumenten voor onderzoek naar roken en stoppen met roken. Den Haag: Stivoro, 2000.
34. van Assema P, Brug J, Ronda G, et al. The relative validity of a short Dutch questionnaire as a means to categorize adults and adolescents to total and saturated fat intake. Journal of human nutrition and dietetics 2001;14:377-90.
35. Van Assema P, Brug J, Ronda G, et al. A short Dutch questionnaire to measure fruit and vegetable intake: relative validity among adults and adolescents. Nutr Health 2002;16:85-106.
36. Harada ND, Chiu V, King AC, et al. An evaluation of three self-report physical activity instruments for older adults. Med Sci Sports Exerc 2001;33:962-70.
37. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
38. Burgers JS, Simoons ML, Hoes AW, et al. Richtlijn Cardiovasculair Risicomanagement. Ned Tijdschr Geneeskd 2007;151:1068-74.
39. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-9.
40. Perera R, Heneghan C, Yudkin P. Graphical method for depicting randomised trials of complex interventions. BMJ 2007;334:127-9.
41. O'Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003;(2):CD001431.
42. Joosten EA, DeFuentes-Merillas L, de Weert GH, et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008;77:219-26.
43. Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012.
44. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ 2003;327:785-9.